Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research
Multiple sclerosis (MS) is a demyelinating disorder of the central nervous system. Disease progression is variable and unpredictable, warranting the development of biomarkers of disease status. Transcranial magnetic stimulation (TMS) is a noninvasive method used to study the human motor system, whic...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2019/6430596 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832559397836947456 |
---|---|
author | Nicholas J. Snow Katie P. Wadden Arthur R. Chaves Michelle Ploughman |
author_facet | Nicholas J. Snow Katie P. Wadden Arthur R. Chaves Michelle Ploughman |
author_sort | Nicholas J. Snow |
collection | DOAJ |
description | Multiple sclerosis (MS) is a demyelinating disorder of the central nervous system. Disease progression is variable and unpredictable, warranting the development of biomarkers of disease status. Transcranial magnetic stimulation (TMS) is a noninvasive method used to study the human motor system, which has shown potential in MS research. However, few reviews have summarized the use of TMS combined with clinical measures of MS and no work has comprehensively assessed study quality. This review explored the viability of TMS as a biomarker in studies of MS examining disease severity, cognitive impairment, motor impairment, or fatigue. Methodological quality and risk of bias were evaluated in studies meeting selection criteria. After screening 1603 records, 30 were included for review. All studies showed high risk of bias, attributed largely to issues surrounding sample size justification, experimenter blinding, and failure to account for key potential confounding variables. Central motor conduction time and motor-evoked potentials were the most commonly used TMS techniques and showed relationships with disease severity, motor impairment, and fatigue. Short-latency afferent inhibition was the only outcome related to cognitive impairment. Although there is insufficient evidence for TMS in clinical assessments of MS, this review serves as a template to inform future research. |
format | Article |
id | doaj-art-187105d7832e49e9973e1ac9c638397e |
institution | Kabale University |
issn | 2090-5904 1687-5443 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | Neural Plasticity |
spelling | doaj-art-187105d7832e49e9973e1ac9c638397e2025-02-03T01:30:05ZengWileyNeural Plasticity2090-59041687-54432019-01-01201910.1155/2019/64305966430596Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future ResearchNicholas J. Snow0Katie P. Wadden1Arthur R. Chaves2Michelle Ploughman3Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, CanadaFaculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, CanadaFaculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, CanadaFaculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, CanadaMultiple sclerosis (MS) is a demyelinating disorder of the central nervous system. Disease progression is variable and unpredictable, warranting the development of biomarkers of disease status. Transcranial magnetic stimulation (TMS) is a noninvasive method used to study the human motor system, which has shown potential in MS research. However, few reviews have summarized the use of TMS combined with clinical measures of MS and no work has comprehensively assessed study quality. This review explored the viability of TMS as a biomarker in studies of MS examining disease severity, cognitive impairment, motor impairment, or fatigue. Methodological quality and risk of bias were evaluated in studies meeting selection criteria. After screening 1603 records, 30 were included for review. All studies showed high risk of bias, attributed largely to issues surrounding sample size justification, experimenter blinding, and failure to account for key potential confounding variables. Central motor conduction time and motor-evoked potentials were the most commonly used TMS techniques and showed relationships with disease severity, motor impairment, and fatigue. Short-latency afferent inhibition was the only outcome related to cognitive impairment. Although there is insufficient evidence for TMS in clinical assessments of MS, this review serves as a template to inform future research.http://dx.doi.org/10.1155/2019/6430596 |
spellingShingle | Nicholas J. Snow Katie P. Wadden Arthur R. Chaves Michelle Ploughman Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research Neural Plasticity |
title | Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research |
title_full | Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research |
title_fullStr | Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research |
title_full_unstemmed | Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research |
title_short | Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research |
title_sort | transcranial magnetic stimulation as a potential biomarker in multiple sclerosis a systematic review with recommendations for future research |
url | http://dx.doi.org/10.1155/2019/6430596 |
work_keys_str_mv | AT nicholasjsnow transcranialmagneticstimulationasapotentialbiomarkerinmultiplesclerosisasystematicreviewwithrecommendationsforfutureresearch AT katiepwadden transcranialmagneticstimulationasapotentialbiomarkerinmultiplesclerosisasystematicreviewwithrecommendationsforfutureresearch AT arthurrchaves transcranialmagneticstimulationasapotentialbiomarkerinmultiplesclerosisasystematicreviewwithrecommendationsforfutureresearch AT michelleploughman transcranialmagneticstimulationasapotentialbiomarkerinmultiplesclerosisasystematicreviewwithrecommendationsforfutureresearch |